Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled time : 08:20 save search
Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236
Published: 2023-10-22 (Crawled : 08:20) - globenewswire.com
RVMD | $37.0 1.57% 400K
|
Health Technology
| Email alert
Add to watchlist
rmc-6236 trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages HUB Cyber Security Ltd. f/k/a Hub Cyber Security (Israel) Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBC, HUBCZ, HUBCW
Published: 2023-09-23 (Crawled : 08:20) - prnewswire.com
RNER | $4.99 20.24% 0
|
n/a
| Email alert
Add to watchlist
RTX | $101.565 0.01% 3.3M
|
Electronic Technology
| Email alert
Add to watchlist
FOUR 4 | $62.15 1.85% 290K
|
Commercial Services
| Email alert
Add to watchlist
HUBC | $1.26 -5.26% 650K
|
n/a
| Email alert
Add to watchlist
security deadline trial
Clinical trial management system (CTMS) market size to increase by USD 1,449.16 million between 2022 and 2027; Growth driven by increasing healthcare expenditure - Technavio
Published: 2023-03-11 (Crawled : 08:20) - prnewswire.com
VEEV | $203.01 1.98% 190K
|
Technology Services
| Email alert
Add to watchlist
management system trial growth market
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
Published: 2022-09-10 (Crawled : 08:20) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
| Email alert
Add to watchlist
biopharma trial
Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
Published: 2022-07-10 (Crawled : 08:20) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
flt180 trial positive international
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
Published: 2022-06-25 (Crawled : 08:20) - globenewswire.com
IMCR | $57.49 2.99% 55K
|
Manufacturing
| Email alert
Add to watchlist
immtav hepatitis liver trial presentation international phase 1 chronic hepatitis b
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
Published: 2015-02-19 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.765 0.24% 22K
|
Health Technology
| Email alert
Add to watchlist
phase 2 lung cancer positive cancer trial mm-120 biomarkers
Gainers vs Losers
| 88% | 12% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.14 39.56% 7.6M
|
Finance
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.